These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 16003747

  • 1. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.
    Carreón T, Ruder AM, Schulte PA, Hayes RB, Rothman N, Waters M, Grant DJ, Boissy R, Bell DA, Kadlubar FF, Hemstreet GP, Yin S, LeMasters GK.
    Int J Cancer; 2006 Jan 01; 118(1):161-8. PubMed ID: 16003747
    [Abstract] [Full Text] [Related]

  • 2. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardón A, Serra C, Carrato A, García-Closas R, Lloreta J, Castaño-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Torà M, Fernández F, Real FX, Rothman N.
    Lancet; 2006 Jan 01; 366(9486):649-59. PubMed ID: 16112301
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers.
    Hayes RB, Bi W, Rothman N, Broly F, Caporaso N, Feng P, You X, Yin S, Woosley RL, Meyer UA.
    Carcinogenesis; 1993 Apr 01; 14(4):675-8. PubMed ID: 8472331
    [Abstract] [Full Text] [Related]

  • 5. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S, Blaszkewicz M, Ickstadt K, Hengstler JG, Golka K.
    Arch Toxicol; 2013 Dec 01; 87(12):2129-39. PubMed ID: 24221535
    [Abstract] [Full Text] [Related]

  • 6. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers.
    Rothman N, Bhatnagar VK, Hayes RB, Zenser TV, Kashyap SK, Butler MA, Bell DA, Lakshmi V, Jaeger M, Kashyap R, Hirvonen A, Schulte PA, Dosemeci M, Hsu F, Parikh DJ, Davis BB, Talaska G.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5084-9. PubMed ID: 8643532
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human N-acetylation of benzidine: role of NAT1 and NAT2.
    Zenser TV, Lakshmi VM, Rustan TD, Doll MA, Deitz AC, Davis BB, Hein DW.
    Cancer Res; 1996 Sep 01; 56(17):3941-7. PubMed ID: 8752161
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts.
    Rothman N, Hayes RB, Zenser TV, DeMarini DM, Bi W, Hirvonen A, Talaska G, Bhatnagar VK, Caporaso NE, Brooks LR, Lakshmi VM, Feng P, Kashyap SK, You X, Eischen BT, Kashyap R, Shelton ML, Hsu FF, Jaeger M, Parikh DJ, Davis BB, Yin S, Bell DA.
    Cancer Epidemiol Biomarkers Prev; 1996 Dec 01; 5(12):979-83. PubMed ID: 8959320
    [Abstract] [Full Text] [Related]

  • 11. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.
    Golka K, Prior V, Blaszkewicz M, Bolt HM.
    Toxicol Lett; 2002 Mar 10; 128(1-3):229-41. PubMed ID: 11869833
    [Abstract] [Full Text] [Related]

  • 12. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.
    Moore LE, Baris DR, Figueroa JD, Garcia-Closas M, Karagas MR, Schwenn MR, Johnson AT, Lubin JH, Hein DW, Dagnall CL, Colt JS, Kida M, Jones MA, Schned AR, Cherala SS, Chanock SJ, Cantor KP, Silverman DT, Rothman N.
    Carcinogenesis; 2011 Feb 10; 32(2):182-9. PubMed ID: 21037224
    [Abstract] [Full Text] [Related]

  • 13. Polymorphism of N-acetyltransferase 2 (NAT2) gene polymorphism in shanghai population: occupational and non-occupational bladder cancer patient groups.
    Ma QW, Lin GF, Chen JG, Xiang CQ, Guo WC, Golka K, Shen JH.
    Biomed Environ Sci; 2004 Sep 10; 17(3):291-8. PubMed ID: 15602826
    [Abstract] [Full Text] [Related]

  • 14. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M, Michaud D, De Vivo I.
    BMC Cancer; 2006 Oct 06; 6():239. PubMed ID: 17026750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. N-acetyltransferase 2 phenotype, occupation, and bladder cancer risk: results from the EPIC cohort.
    Pesch B, Gawrych K, Rabstein S, Weiss T, Casjens S, Rihs HP, Ding H, Angerer J, Illig T, Klopp N, Bueno-de-Mesquita B, Ros MM, Kaaks R, Chang-Claude J, Roswall N, Tjønneland A, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Dossus L, Boeing H, Weikert S, Trichopoulos D, Palli D, Sieri S, Tumino R, Panico S, Quirós JR, González C, Sánchez MJ, Dorronsoro M, Navarro C, Barricarte A, Ljungberg B, Johansson M, Ulmert D, Ehrnström R, Khaw KT, Wareham N, Key TJ, Ferrari P, Romieu I, Riboli E, Brüning T, Vineis P.
    Cancer Epidemiol Biomarkers Prev; 2013 Nov 06; 22(11):2055-65. PubMed ID: 24092628
    [Abstract] [Full Text] [Related]

  • 18. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM, Bell DA, Watson MA, Skipper PL, Tannenbaum SR, Chan KK, Ross RK, Yu MC.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun 06; 9(6):619-23. PubMed ID: 10868698
    [Abstract] [Full Text] [Related]

  • 19. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C, Verla-Tebit E, Risch A, Jäger B, Hoffmeister M, Brenner H, Chang-Claude J.
    Cancer Epidemiol Biomarkers Prev; 2006 Jan 06; 15(1):99-107. PubMed ID: 16434594
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.